Description: Sutro Biopharma, Inc. is a public biotechnology company headquartered in South San Francisco, California focused on clinical stage drug discovery, development and manufacturing company. Using its integrated cell-free protein synthesis platform, XpressCF, to create a variety of protein therapeutics for cancer and autoimmune disorders. It focuses to design therapeutics using potent modalities, including cytokine based immune-oncology (I/O) therapeutics, antibody-drug conjugates (ADCs) and bispecific antibodie
cancer (3313) biotechnology (788) oncology (589) biopharma (79) south san francisco (57) biopharm (19) ssf (19) sutro (4) cell-free protein synthesis (3) clinical stage drug discovery (2)
Sutro Biopharma is working independently and with partners to develop novel cancer therapies, including antibody-drug conjugates, bispecific antibodies and cytokine derivatives targeting immuno-oncology pathways.
Sutro is honored to be named, BioSpace Best Places to Work for 2023. Many thanks to our Sutro team for their continuous efforts in placing our patients first. We appreciate and value all the work you have done!
To read the report, click the link .